Association of EMs with rHEa

EMUnadjustedAdjustedb
OR (95% CI)P ValueOR (95% CI)P Value
Barras density1.96 (0.95–4.08).071.11 (0.46–2.66).81
Black hole8.66 (2.15–58.14).007c5.62 (1.23–40.23).03c
Blend2.90 (1.08–8.38).04c1.45 (0.43–4.99).55
Fluid level0.38 (0.06–1.67).250.35 (0.05–1.60).18
Hypodensity3.18 (1.49–6.93).003c2.01 (0.77–5.31).15
Swirl1.91 (0.87–4.37).121.20 (0.48–3.05).70
Barras shape2.41 (1.17–5.10).02c1.48 (0.63–3.51).37
Island1.37 (0.53–3.55).510.49 (0.12–1.72).27
Satellite2.84 (1.29–6.61).01c1.73 (0.68–4.57).25
Combined EMs
 Any shape marker2.90 (1.26–7.18).02c1.87 (0.69–5.38).22
 Any density marker1.76 (0.74–4.44).210.93 (0.34–2.68).90
 Shape marker count1.57 (1.11–2.27).01c1.17 (0.73–1.87).51
 Density marker count1.51 (1.16–1.99).003c1.27 (0.87–1.86).21
 Any EM2.38 (0.85–7.75).121.33 (0.41–4.87).64
 EM count1.33 (1.12–1.60).002c1.20 (0.91–1.58).20
 Expansion-prone hematoma2.50 (1.16–5.50).02c1.30 (0.45–3.69).63
  • a Revised hematoma expansion was defined as any of a ≥ 6-mL or ≥33% increase in ICH volume, a ≥ 1-mL increase in intraventricular hemorrhage volume, or de novo intraventricular hemorrhage.

  • b Adjusted for antiplatelet use, anticoagulant use, baseline ICH volume, and last-seen-well to initial CT.

  • c P < .05.